«Our study's positive results may lead the way to developing a more
targeted therapy using steroids to quickly restore the integrity and function of the BBB after bTBI.»
Targeted therapy using MDSC - inhibiting drugs, such as cabozantinib (Cabo) and BEZ, also demonstrated minimal anti-tumor capabilities.
The primary aim is to investigate the use of
targeted therapy using antibodies and antibody - conjugates and remove toxic chemotherapy and radiation from the treatment to maintain high cure rates and decrease late effects.
Bottom Line: Young mice that received molecularly
targeted therapies used to treat brain cancer in human patients sustained cognitive and behavioral deficits, but the deficits were largely reversible through environmental stimulation and physical exercise.
Not exact matches
The start - up's premiere product, the Thin Ice vest,
uses cold
therapy to
target areas of the body with high concentrations of thermoreceptors, which are nerve cells that are able to detect the presence of hot or cold temperatures.
Gene
therapy, for example, frequently involves
using a virus to deliver a gene to the cells that scientists are
targeting.
«The sale of the PRV provides an important source of non-dilutive capital to support the rapid advancement of our follow on exon skipping candidates and next generation RNA
targeted antisense platform,» he said in a statement, referring to the action mechanism
used by the company's
therapies.
• The
use of biotech to provide precision medicine for
targeted therapies.
Cambridge, MA — February 6, 2017 — Aura Biosciences, a biotechnology company developing a new class of
therapies to
target and selectively destroy cancer cells
using viral nanoparticle conjugates, announced today that the U.S. Food and Drug Administration (FDA) has cleared the investigational new drug application (IND) for the company's lead program, light - activated AU - 011 in ocular melanoma (OM).
Cambridge, MA — December 21, 2017 — Aura Biosciences, a biotechnology company developing a new class of
therapies to
target and selectively destroy cancer cells
using viral nanoparticle conjugates, announced today that it closed a $ 30 million Series C financing.
Cambridge, MA — March 30, 2017 — Aura Biosciences, a biotechnology company developing a new class of
therapies to
target and selectively destroy cancer cells
using viral nanoparticle conjugates, announced today that it has enrolled and dosed the first patient in its Phase 1b clinical trial of light - activated AU - 011, an investigational, first - in - class
targeted therapy in development for the treatment of ocular melanoma, a rare and life - threatening disease.
But I think it is long past time to consider the value of other approaches, including the
targeted use of drug
therapies.
Drugs that impact DNA methylation are increasingly a
target for drug development; in fact, several of these
therapies are already in clinical
use for certain cancers.
Unlike conventional chemotherapies and radiation that indiscriminately eradicate fast - growing tissues and ravage people's bodies with side effects, new
therapies specifically
target tumors
using tailored cells from individual patients.
Prof. Severine Vermeire (KU Leuven / UZ Leuven): «In the future, gut bacteria may be
used to help identify PSC patients with a more or less aggressive disease, or patients that may benefit from microbiota - based
therapies, such as fecal microbiota transplantation or
targeted pre - and probiotics.»
The finding suggests that other AAVs
used for a gene
therapy targeting the brain or spinal cord might be improved by having the same or a similar set of amino acids.
To address this challenge, our research group is
using nanoparticles not only to deliver more chemotherapy drugs to the
target site within cancer cells, but also to compromise the function of the efflux pumps and thereby significantly improve safety and efficacy of cancer
therapy.»
«We were hoping to find
targets we can
use for
therapy and we were also trying to figure out molecular differences in different types of epilepsy.
However, they determined the blood levels of SMN are not altered when SMN levels are altered in motor neurons
using a gene
therapy approach delivered directly into the cerebrospinal fluid to
target the central nervous system.
Importantly, while
using rosiglitazone in conjunction with
targeted therapy reduced tumor growth in both young and aged pre-clinical models,
using rosiglitazone alone accelerated tumor growth in young models, while inhibiting it in aged ones.
This new technology offers two main advantages based on the
use of molecular tools to manipulate the genome: firstly, working models that had not existed up until now for the study of tumour biology and, secondly, their application will eventually allow for the study of new therapeutic
targets and
therapies.
Researchers at The University of Texas MD Anderson Cancer Center developed a novel chimeric mouse model to test the combination
therapy using immune checkpoint blockades with
therapies targeting myeloid - derived suppressor cells (MDSCs).
«Inhibiting mTOR signaling
using everolimus, a
targeted therapy, known as a rapalog, for patients with lung and gastroenteropancreatic NETs, has been approved by the FDA.
The researchers found a set of frequently mutated genes in SBAs that could be helpful to clinicians when they are looking to
use targeted therapies that work best in cancers with specifics mutations.
«In order to block tumor recurrence after radiation
therapy, we
used an antibody to
target and inhibit these cancer stem cells,» said Dr. Xu.
Treatment for advanced melanoma has seen success with
targeted therapies — drugs that interfere with division and growth of cancer cells by
targeting key molecules — especially when multiple drugs are
used in combination.
These results not only show promise on a new
targeted therapy to treat this malignancy, as PI3K inhibitors are already
used in the clinical practice, but also unravel a new function of the PI3K kinase in cancer biology through its role in promoting metastasis.
One way to do this is to
use combinations of
targeted therapies.
While this could not heal or replace an entire body's worth of diseased muscle, it could be
used in tandem with more widely
targeted genetic
therapies or to heal more localized problems.
«Potential
targeted therapy for lung cancer identified
using fly model.»
«Knowing how language learners make
use of statistical information may suggest ways we can
target language
therapies,» says Goldrick.
The researchers were able to reverse these epigenetic changes with the
use of an FDA - approved drug, forcing the cancer cells out of hiding and potentially making them better
targets for the same immune
therapy that in the past may have failed.
Taken together, the results suggest a role for bile duct tissue microbiome in development of CCA and which may accordingly be
used as a
target for
therapy.
The advantage of proton
therapy is that there may be a procedure I could undergo in the future that
uses targeted radiation to
target the tumorous tissue and that could potentially kill off my tumor.
A research group at Boston's Massachusetts General Hospital, led by Tayyaba Hasan, has
used nanocells and photodynamic
therapy (light - activated chemicals) to
target pancreatic cancer.
As for the future of adolescent substance
use treatment, Drs. Chung & Black describe a need to focus on the «active ingredients» of
therapies and their respective «
targets.»
«Obviously, this information can be
used in our efforts to identify drug
therapies that kill cancer cells by
targeting telomerase activity.»
Targeted Alpha
Therapy of prostate cancer
uses PSMA - 617, an anti-PSMA (Prostate Specific Membrane Antigen) peptide that specifically binds to prostate cancer cells, but not to normal, healthy cells.
Still, the standard form of liver -
targeted gene
therapy carries a range of potential complications, including the risk of harmful mutations and of the body mounting an immune response against the viral vectors
used to carry the correct forms of the defective genes responsible for haemophilia.
In their report that has received advance online publication in Nature Nanotechnology, a research team based at the Wellman Center for Photomedicine at Massachusetts General Hospital (MGH) describes how a nanomedicine that combines photodynamic
therapy — the
use of light to trigger a chemical reaction — with a molecular
therapy drug
targeted against common treatment resistance pathways reduced a thousand-fold the dosage of the molecular
therapy drug required to suppress tumor progression and metastatic outgrowth in an animal model.
Dr. Jones obtained his Ph.D. in 2003 from the University of Birmingham Institute of Cancer and Genomic Sciences (United Kingdom) under Professor Lawrence Young, studying the
use of gene
therapy for
targeting Epstein - Barr Virus (EBV) proteins with replication - competent adenoviruses to treat EBV - driven malignancies.
As the central nervous system is also a
target of AAV vectors, Hélène Puccio and Patrick Aubourg's teams are investigating whether a similar approach
using gene
therapy could be as effective for the spinal cord and cerebellum as it is for the heart.
The next step in the research should be to study the
use of mindfulness - based
therapies to
target purpose in life and resulting sleep quality, said Arlener Turner, the study's first author and a former postdoctoral fellow in neurology at Feinberg.
Drugs
used in
targeted gene
therapy operate by inhibiting one or more cellular processes.
The radiation
used for cancer
therapies is a much more
targeted version of what exists in outer space, and exposure to that radiation presents a major health risk, and thus a serious challenge for NASA, SpaceX, and other organizations trying to explore the solar system.
Last year, she and her colleagues showed that the
therapy could also be
used to help halt HIV by
targeting one of several viral proteins on the surface of HIV - infected cells.
Thus, finding new
targets for drugs already in
use to treat other diseases, in other words drug repurposing, is an emerging area in developing anti-cancer
therapies.
Testing for the EGFR mutation and ALK rearrangements and the
use of
targeted therapies have given lung cancer patients the chance for survival, along with improved quality of life and time with loved ones.
This method, known as
targeted radionuclide
therapy, or TRT, involves the
use of molecules labeled with radioactive atoms that are injected into patients and localized in cancer cells.
The bots might arrive at a clot, for example, and then
using an internal power system, obliterate the clot with a precisely
targeted drug or
therapy.